The University of Texas at San Antonio (UTSA) and GenCure are working together on the development of cellular therapy products and services under a new master services agreement. GenCure will provide UTSA with research starting materials, and UTSA will offer testing services for materials produced by GenCure. The collaboration aims to boost the clinical application of stem cell therapeutics.
Alzheimer’s treatment: What’s next beyond amyloid?
In the face of rising global Alzheimer’s rates, a broader range of approaches towards finding a cure is in motion. Apart from the traditional approach
